▶ 調査レポート

世界の治療薬モニタリング市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Therapeutic Drug Monitoring Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の治療薬モニタリング市場規模・現状・予測(2021年-2027年) / Global Therapeutic Drug Monitoring Market Size, Status and Forecast 2021-2027 / QYR2104Z5616資料のイメージです。• レポートコード:QYR2104Z5616
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、97ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥553,800 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥830,700 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,107,600 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、治療薬モニタリングのグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(血液検査、尿検査、唾液検査、その他検査)、用途別市場規模(病院ラボ、プライベートラボ、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・治療薬モニタリングの市場動向
・企業の競争状況、市場シェア
・治療薬モニタリングの種類別市場規模(血液検査、尿検査、唾液検査、その他検査)
・治療薬モニタリングの用途別市場規模(病院ラボ、プライベートラボ、その他)
・治療薬モニタリングの北米市場規模2016-2027(アメリカ、カナダ)
・治療薬モニタリングのヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・治療薬モニタリングのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・治療薬モニタリングの中南米市場規模2016-2027(メキシコ、ブラジル)
・治療薬モニタリングの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Roche、Danaher、Abbott、Thermo Fisher Scientific、Siemens Healthcare、Bio-Rad Laboratories、BioMerieux、Sanquin、Becton Dickinson、Quest Diagnostics)
・結論

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient’s bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.
Roche, Danaher and Abbott are the major companies in the industry, accounting for 17.17%, 10.36% and 8.29% of the revenue respectively in 2019. By region, North America had the highest share of income, reaching 42.31 percent in 2019.

Market Analysis and Insights: Global Therapeutic Drug Monitoring Market
The global Therapeutic Drug Monitoring market size is projected to reach US$ 2300.1 million by 2026, from US$ 1524.8 million in 2019, at a CAGR of 6.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Therapeutic Drug Monitoring market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Therapeutic Drug Monitoring market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Therapeutic Drug Monitoring market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Therapeutic Drug Monitoring market.

Global Therapeutic Drug Monitoring Scope and Market Size
Therapeutic Drug Monitoring market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Drug Monitoring market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Blood Test
Urine Test
Saliva Test
Other Test
Blood test is one of the largest product segments of the polyurethane market, accounting for over 50% revenue market share in 2019.

Segment by Application
Hospital Labs
Private Labs
Others
Hospital labs holds an important share in terms of applications with a sales market share of over 50% in 2018.

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Danaher
Abbott
Thermo Fisher Scientific
Siemens Healthcare
Bio-Rad Laboratories
BioMerieux
Sanquin
Becton Dickinson

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Drug Monitoring Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Test
1.2.3 Urine Test
1.2.4 Saliva Test
1.2.5 Other Test
1.3 Market by Application
1.3.1 Global Therapeutic Drug Monitoring Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Labs
1.3.3 Private Labs
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Therapeutic Drug Monitoring Market Perspective (2016-2027)
2.2 Therapeutic Drug Monitoring Growth Trends by Regions
2.2.1 Therapeutic Drug Monitoring Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Therapeutic Drug Monitoring Historic Market Share by Regions (2016-2021)
2.2.3 Therapeutic Drug Monitoring Forecasted Market Size by Regions (2022-2027)
2.3 Therapeutic Drug Monitoring Industry Dynamic
2.3.1 Therapeutic Drug Monitoring Market Trends
2.3.2 Therapeutic Drug Monitoring Market Drivers
2.3.3 Therapeutic Drug Monitoring Market Challenges
2.3.4 Therapeutic Drug Monitoring Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Drug Monitoring Players by Revenue
3.1.1 Global Top Therapeutic Drug Monitoring Players by Revenue (2016-2021)
3.1.2 Global Therapeutic Drug Monitoring Revenue Market Share by Players (2016-2021)
3.2 Global Therapeutic Drug Monitoring Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Therapeutic Drug Monitoring Revenue
3.4 Global Therapeutic Drug Monitoring Market Concentration Ratio
3.4.1 Global Therapeutic Drug Monitoring Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Drug Monitoring Revenue in 2020
3.5 Therapeutic Drug Monitoring Key Players Head office and Area Served
3.6 Key Players Therapeutic Drug Monitoring Product Solution and Service
3.7 Date of Enter into Therapeutic Drug Monitoring Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Therapeutic Drug Monitoring Breakdown Data by Type
4.1 Global Therapeutic Drug Monitoring Historic Market Size by Type (2016-2021)
4.2 Global Therapeutic Drug Monitoring Forecasted Market Size by Type (2022-2027)

5 Therapeutic Drug Monitoring Breakdown Data by Application
5.1 Global Therapeutic Drug Monitoring Historic Market Size by Application (2016-2021)
5.2 Global Therapeutic Drug Monitoring Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Therapeutic Drug Monitoring Market Size (2016-2027)
6.2 North America Therapeutic Drug Monitoring Market Size by Type
6.2.1 North America Therapeutic Drug Monitoring Market Size by Type (2016-2021)
6.2.2 North America Therapeutic Drug Monitoring Market Size by Type (2022-2027)
6.2.3 North America Therapeutic Drug Monitoring Market Size by Type (2016-2027)
6.3 North America Therapeutic Drug Monitoring Market Size by Application
6.3.1 North America Therapeutic Drug Monitoring Market Size by Application (2016-2021)
6.3.2 North America Therapeutic Drug Monitoring Market Size by Application (2022-2027)
6.3.3 North America Therapeutic Drug Monitoring Market Size by Application (2016-2027)
6.4 North America Therapeutic Drug Monitoring Market Size by Country
6.4.1 North America Therapeutic Drug Monitoring Market Size by Country (2016-2021)
6.4.2 North America Therapeutic Drug Monitoring Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Therapeutic Drug Monitoring Market Size (2016-2027)
7.2 Europe Therapeutic Drug Monitoring Market Size by Type
7.2.1 Europe Therapeutic Drug Monitoring Market Size by Type (2016-2021)
7.2.2 Europe Therapeutic Drug Monitoring Market Size by Type (2022-2027)
7.2.3 Europe Therapeutic Drug Monitoring Market Size by Type (2016-2027)
7.3 Europe Therapeutic Drug Monitoring Market Size by Application
7.3.1 Europe Therapeutic Drug Monitoring Market Size by Application (2016-2021)
7.3.2 Europe Therapeutic Drug Monitoring Market Size by Application (2022-2027)
7.3.3 Europe Therapeutic Drug Monitoring Market Size by Application (2016-2027)
7.4 Europe Therapeutic Drug Monitoring Market Size by Country
7.4.1 Europe Therapeutic Drug Monitoring Market Size by Country (2016-2021)
7.4.2 Europe Therapeutic Drug Monitoring Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Drug Monitoring Market Size (2016-2027)
8.2 Asia-Pacific Therapeutic Drug Monitoring Market Size by Type
8.2.1 Asia-Pacific Therapeutic Drug Monitoring Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Therapeutic Drug Monitoring Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Therapeutic Drug Monitoring Market Size by Type (2016-2027)
8.3 Asia-Pacific Therapeutic Drug Monitoring Market Size by Application
8.3.1 Asia-Pacific Therapeutic Drug Monitoring Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Therapeutic Drug Monitoring Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Therapeutic Drug Monitoring Market Size by Application (2016-2027)
8.4 Asia-Pacific Therapeutic Drug Monitoring Market Size by Region
8.4.1 Asia-Pacific Therapeutic Drug Monitoring Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Therapeutic Drug Monitoring Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Therapeutic Drug Monitoring Market Size (2016-2027)
9.2 Latin America Therapeutic Drug Monitoring Market Size by Type
9.2.1 Latin America Therapeutic Drug Monitoring Market Size by Type (2016-2021)
9.2.2 Latin America Therapeutic Drug Monitoring Market Size by Type (2022-2027)
9.2.3 Latin America Therapeutic Drug Monitoring Market Size by Type (2016-2027)
9.3 Latin America Therapeutic Drug Monitoring Market Size by Application
9.3.1 Latin America Therapeutic Drug Monitoring Market Size by Application (2016-2021)
9.3.2 Latin America Therapeutic Drug Monitoring Market Size by Application (2022-2027)
9.3.3 Latin America Therapeutic Drug Monitoring Market Size by Application (2016-2027)
9.4 Latin America Therapeutic Drug Monitoring Market Size by Country
9.4.1 Latin America Therapeutic Drug Monitoring Market Size by Country (2016-2021)
9.4.2 Latin America Therapeutic Drug Monitoring Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Drug Monitoring Market Size (2016-2027)
10.2 Middle East & Africa Therapeutic Drug Monitoring Market Size by Type
10.2.1 Middle East & Africa Therapeutic Drug Monitoring Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Therapeutic Drug Monitoring Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Therapeutic Drug Monitoring Market Size by Type (2016-2027)
10.3 Middle East & Africa Therapeutic Drug Monitoring Market Size by Application
10.3.1 Middle East & Africa Therapeutic Drug Monitoring Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Therapeutic Drug Monitoring Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Therapeutic Drug Monitoring Market Size by Application (2016-2027)
10.4 Middle East & Africa Therapeutic Drug Monitoring Market Size by Country
10.4.1 Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Therapeutic Drug Monitoring Introduction
11.1.4 Roche Revenue in Therapeutic Drug Monitoring Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Danaher
11.2.1 Danaher Company Details
11.2.2 Danaher Business Overview
11.2.3 Danaher Therapeutic Drug Monitoring Introduction
11.2.4 Danaher Revenue in Therapeutic Drug Monitoring Business (2016-2021)
11.2.5 Danaher Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Therapeutic Drug Monitoring Introduction
11.3.4 Abbott Revenue in Therapeutic Drug Monitoring Business (2016-2021)
11.3.5 Abbott Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Introduction
11.4.4 Thermo Fisher Scientific Revenue in Therapeutic Drug Monitoring Business (2016-2021)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Details
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Therapeutic Drug Monitoring Introduction
11.5.4 Siemens Healthcare Revenue in Therapeutic Drug Monitoring Business (2016-2021)
11.5.5 Siemens Healthcare Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Introduction
11.6.4 Bio-Rad Laboratories Revenue in Therapeutic Drug Monitoring Business (2016-2021)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Details
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux Therapeutic Drug Monitoring Introduction
11.7.4 BioMerieux Revenue in Therapeutic Drug Monitoring Business (2016-2021)
11.7.5 BioMerieux Recent Development
11.8 Sanquin
11.8.1 Sanquin Company Details
11.8.2 Sanquin Business Overview
11.8.3 Sanquin Therapeutic Drug Monitoring Introduction
11.8.4 Sanquin Revenue in Therapeutic Drug Monitoring Business (2016-2021)
11.8.5 Sanquin Recent Development
11.9 Becton Dickinson
11.9.1 Becton Dickinson Company Details
11.9.2 Becton Dickinson Business Overview
11.9.3 Becton Dickinson Therapeutic Drug Monitoring Introduction
11.9.4 Becton Dickinson Revenue in Therapeutic Drug Monitoring Business (2016-2021)
11.9.5 Becton Dickinson Recent Development
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Details
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Therapeutic Drug Monitoring Introduction
11.10.4 Quest Diagnostics Revenue in Therapeutic Drug Monitoring Business (2016-2021)
11.10.5 Quest Diagnostics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Therapeutic Drug Monitoring Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Blood Test
Table 3. Key Players of Urine Test
Table 4. Key Players of Saliva Test
Table 5. Key Players of Other Test
Table 6. Global Therapeutic Drug Monitoring Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Therapeutic Drug Monitoring Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Therapeutic Drug Monitoring Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Therapeutic Drug Monitoring Market Share by Regions (2016-2021)
Table 10. Global Therapeutic Drug Monitoring Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Therapeutic Drug Monitoring Market Share by Regions (2022-2027)
Table 12. Therapeutic Drug Monitoring Market Trends
Table 13. Therapeutic Drug Monitoring Market Drivers
Table 14. Therapeutic Drug Monitoring Market Challenges
Table 15. Therapeutic Drug Monitoring Market Restraints
Table 16. Global Therapeutic Drug Monitoring Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Therapeutic Drug Monitoring Market Share by Players (2016-2021)
Table 18. Global Top Therapeutic Drug Monitoring Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Drug Monitoring as of 2020)
Table 19. Ranking of Global Top Therapeutic Drug Monitoring Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Therapeutic Drug Monitoring Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Therapeutic Drug Monitoring Product Solution and Service
Table 23. Date of Enter into Therapeutic Drug Monitoring Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Therapeutic Drug Monitoring Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Therapeutic Drug Monitoring Revenue Market Share by Type (2016-2021)
Table 27. Global Therapeutic Drug Monitoring Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Therapeutic Drug Monitoring Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Therapeutic Drug Monitoring Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Therapeutic Drug Monitoring Revenue Market Share by Application (2016-2021)
Table 31. Global Therapeutic Drug Monitoring Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Therapeutic Drug Monitoring Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Therapeutic Drug Monitoring Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Therapeutic Drug Monitoring Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Therapeutic Drug Monitoring Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Therapeutic Drug Monitoring Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Therapeutic Drug Monitoring Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Therapeutic Drug Monitoring Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Therapeutic Drug Monitoring Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Therapeutic Drug Monitoring Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Therapeutic Drug Monitoring Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Therapeutic Drug Monitoring Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Therapeutic Drug Monitoring Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Therapeutic Drug Monitoring Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Therapeutic Drug Monitoring Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Therapeutic Drug Monitoring Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Therapeutic Drug Monitoring Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Therapeutic Drug Monitoring Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Therapeutic Drug Monitoring Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Therapeutic Drug Monitoring Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Therapeutic Drug Monitoring Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Therapeutic Drug Monitoring Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Therapeutic Drug Monitoring Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Therapeutic Drug Monitoring Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Therapeutic Drug Monitoring Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Therapeutic Drug Monitoring Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Therapeutic Drug Monitoring Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Therapeutic Drug Monitoring Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Therapeutic Drug Monitoring Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Therapeutic Drug Monitoring Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Therapeutic Drug Monitoring Product
Table 66. Roche Revenue in Therapeutic Drug Monitoring Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Danaher Company Details
Table 69. Danaher Business Overview
Table 70. Danaher Therapeutic Drug Monitoring Product
Table 71. Danaher Revenue in Therapeutic Drug Monitoring Business (2016-2021) & (US$ Million)
Table 72. Danaher Recent Development
Table 73. Abbott Company Details
Table 74. Abbott Business Overview
Table 75. Abbott Therapeutic Drug Monitoring Product
Table 76. Abbott Revenue in Therapeutic Drug Monitoring Business (2016-2021) & (US$ Million)
Table 77. Abbott Recent Development
Table 78. Thermo Fisher Scientific Company Details
Table 79. Thermo Fisher Scientific Business Overview
Table 80. Thermo Fisher Scientific Therapeutic Drug Monitoring Product
Table 81. Thermo Fisher Scientific Revenue in Therapeutic Drug Monitoring Business (2016-2021) & (US$ Million)
Table 82. Thermo Fisher Scientific Recent Development
Table 83. Siemens Healthcare Company Details
Table 84. Siemens Healthcare Business Overview
Table 85. Siemens Healthcare Therapeutic Drug Monitoring Product
Table 86. Siemens Healthcare Revenue in Therapeutic Drug Monitoring Business (2016-2021) & (US$ Million)
Table 87. Siemens Healthcare Recent Development
Table 88. Bio-Rad Laboratories Company Details
Table 89. Bio-Rad Laboratories Business Overview
Table 90. Bio-Rad Laboratories Therapeutic Drug Monitoring Product
Table 91. Bio-Rad Laboratories Revenue in Therapeutic Drug Monitoring Business (2016-2021) & (US$ Million)
Table 92. Bio-Rad Laboratories Recent Development
Table 93. BioMerieux Company Details
Table 94. BioMerieux Business Overview
Table 95. BioMerieux Therapeutic Drug Monitoring Product
Table 96. BioMerieux Revenue in Therapeutic Drug Monitoring Business (2016-2021) & (US$ Million)
Table 97. BioMerieux Recent Development
Table 98. Sanquin Company Details
Table 99. Sanquin Business Overview
Table 100. Sanquin Revenue in Therapeutic Drug Monitoring Business (2016-2021) & (US$ Million)
Table 101. Sanquin Recent Development
Table 102. Becton Dickinson Company Details
Table 103. Becton Dickinson Business Overview
Table 104. Becton Dickinson Therapeutic Drug Monitoring Product
Table 105. Becton Dickinson Revenue in Therapeutic Drug Monitoring Business (2016-2021) & (US$ Million)
Table 106. Becton Dickinson Recent Development
Table 107. Quest Diagnostics Company Details
Table 108. Quest Diagnostics Business Overview
Table 109. Quest Diagnostics Therapeutic Drug Monitoring Product
Table 110. Quest Diagnostics Revenue in Therapeutic Drug Monitoring Business (2016-2021) & (US$ Million)
Table 111. Quest Diagnostics Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Therapeutic Drug Monitoring Market Share by Type: 2020 VS 2027
Figure 2. Blood Test Features
Figure 3. Urine Test Features
Figure 4. Saliva Test Features
Figure 5. Other Test Features
Figure 6. Global Therapeutic Drug Monitoring Market Share by Application: 2020 VS 2027
Figure 7. Hospital Labs Case Studies
Figure 8. Private Labs Case Studies
Figure 9. Others Case Studies
Figure 10. Therapeutic Drug Monitoring Report Years Considered
Figure 11. Global Therapeutic Drug Monitoring Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Therapeutic Drug Monitoring Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Therapeutic Drug Monitoring Market Share by Regions: 2020 VS 2027
Figure 14. Global Therapeutic Drug Monitoring Market Share by Regions (2022-2027)
Figure 15. Global Therapeutic Drug Monitoring Market Share by Players in 2020
Figure 16. Global Top Therapeutic Drug Monitoring Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Drug Monitoring as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Therapeutic Drug Monitoring Revenue in 2020
Figure 18. Global Therapeutic Drug Monitoring Revenue Market Share by Type (2016-2021)
Figure 19. Global Therapeutic Drug Monitoring Revenue Market Share by Type (2022-2027)
Figure 20. North America Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Therapeutic Drug Monitoring Market Share by Type (2016-2027)
Figure 22. North America Therapeutic Drug Monitoring Market Share by Application (2016-2027)
Figure 23. North America Therapeutic Drug Monitoring Market Share by Country (2016-2027)
Figure 24. United States Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Therapeutic Drug Monitoring Market Share by Type (2016-2027)
Figure 28. Europe Therapeutic Drug Monitoring Market Share by Application (2016-2027)
Figure 29. Europe Therapeutic Drug Monitoring Market Share by Country (2016-2027)
Figure 30. Germany Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Therapeutic Drug Monitoring Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Therapeutic Drug Monitoring Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Therapeutic Drug Monitoring Market Share by Region (2016-2027)
Figure 40. China Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Therapeutic Drug Monitoring Market Share by Type (2016-2027)
Figure 48. Latin America Therapeutic Drug Monitoring Market Share by Application (2016-2027)
Figure 49. Latin America Therapeutic Drug Monitoring Market Share by Country (2016-2027)
Figure 50. Mexico Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Therapeutic Drug Monitoring Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Therapeutic Drug Monitoring Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Therapeutic Drug Monitoring Market Share by Country (2016-2027)
Figure 56. Turkey Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Therapeutic Drug Monitoring Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Therapeutic Drug Monitoring Business (2016-2021)
Figure 60. Danaher Revenue Growth Rate in Therapeutic Drug Monitoring Business (2016-2021)
Figure 61. Abbott Revenue Growth Rate in Therapeutic Drug Monitoring Business (2016-2021)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Therapeutic Drug Monitoring Business (2016-2021)
Figure 63. Siemens Healthcare Revenue Growth Rate in Therapeutic Drug Monitoring Business (2016-2021)
Figure 64. Bio-Rad Laboratories Revenue Growth Rate in Therapeutic Drug Monitoring Business (2016-2021)
Figure 65. BioMerieux Revenue Growth Rate in Therapeutic Drug Monitoring Business (2016-2021)
Figure 66. Sanquin Revenue Growth Rate in Therapeutic Drug Monitoring Business (2016-2021)
Figure 67. Becton Dickinson Revenue Growth Rate in Therapeutic Drug Monitoring Business (2016-2021)
Figure 68. Quest Diagnostics Revenue Growth Rate in Therapeutic Drug Monitoring Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed